Bend Research gets EU GMP certificate

The Swedish Medical Products Agency (MPA) has granted Bend Research a certificate of compliance with European Union good manufacturing practice (GMP) regulations for the company’s manufacture and testing of clinical pharmaceutical supplies. All European health authorities recognize the MPA GMP certificate, as do agencies in some additional countries.

Bend CEO Rod Ray commented, “The strategic addition of this certification—combined with new capabilities such as high-potency spray‑drying and future commercial spray‑drying—strengthens Bend Research’s position as a preferred provider for oral solubilized, modified-release, inhalation, and many other dosage forms.”

The company produced 136 clinical manufacturing lots for 16 clients in 2012.

Read the Bend Research press release.

Share

published on

December 9-December 11: DDL 2026, Edinburgh, Scotland

April 27-30: RDD Europe 2027, Antibes, France

June 30: RespireX 2027, Boston, MA, USA